600998 Stock Overview
Provides pharmaceutical supply chain services in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Jointown Pharmaceutical Group Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.33 |
| 52 Week High | CN¥6.94 |
| 52 Week Low | CN¥4.35 |
| Beta | 0.21 |
| 11 Month Change | 1.52% |
| 3 Month Change | 14.62% |
| 1 Year Change | -8.08% |
| 33 Year Change | 3.63% |
| 5 Year Change | 11.53% |
| Change since IPO | -9.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600998 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -3.4% | -2.5% | -2.8% |
| 1Y | -8.1% | -16.7% | 2.0% |
Return vs Industry: 600998 exceeded the CN Healthcare industry which returned -16.7% over the past year.
Return vs Market: 600998 underperformed the CN Market which returned 2% over the past year.
Price Volatility
| 600998 volatility | |
|---|---|
| 600998 Average Weekly Movement | 6.6% |
| Healthcare Industry Average Movement | 8.7% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 600998 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600998's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 30,100 | Wei He | www.jztey.com |
Jointown Pharmaceutical Group Co., Ltd provides pharmaceutical supply chain services in China. It is also involved in general agency brand promotion; digital retail; intelligent logistics and supply chain solutions; and medical health and technology value-added service businesses. In addition, the company manufactures western medicines, such as antibiotics, anti-diabetic drugs, and cardiovascular drugs; and other OEM medicines.
Jointown Pharmaceutical Group Co., Ltd Fundamentals Summary
| 600998 fundamental statistics | |
|---|---|
| Market cap | CN¥26.18b |
| Earnings (TTM) | CN¥2.05b |
| Revenue (TTM) | CN¥149.20b |
12.8x
P/E Ratio0.2x
P/S RatioIs 600998 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600998 income statement (TTM) | |
|---|---|
| Revenue | CN¥149.20b |
| Cost of Revenue | CN¥137.45b |
| Gross Profit | CN¥11.75b |
| Other Expenses | CN¥9.70b |
| Earnings | CN¥2.05b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.42 |
| Gross Margin | 7.88% |
| Net Profit Margin | 1.37% |
| Debt/Equity Ratio | 43.1% |
How did 600998 perform over the long term?
See historical performance and comparison